{"id":"NCT01192191","sponsor":"GlaxoSmithKline","briefTitle":"A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD","officialTitle":"A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Japanese Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2010-08-31","resultsPosted":"2013-08-12","lastUpdate":"2017-01-11"},"enrollment":187,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Fluticasone Furoate/GW642444 Inhalation Powder 100/25mcg","otherNames":[]},{"type":"DRUG","name":"Fluticasone Furoate/GW642444 Inhalation Powder 200/25mcg","otherNames":[]}],"arms":[{"label":"Fluticasone Furoate/GW642444 100/25mcg","type":"EXPERIMENTAL"},{"label":"Fluticasone Furoate/GW642444 200/25mcg","type":"EXPERIMENTAL"}],"summary":"The primary purpose of the study is to evaluate the safety and tolerability of fluticasone furoate/GW642444 inhalation powder when administered once-daily for 52 weeks in Japanese patients with COPD.","primaryOutcome":{"measure":"Number of Participants With Any Non-serious Adverse Event (AE) and Any Serious Adverse Event (SAE) Throughout the Treatment Period","timeFrame":"From the start of investigational product to the last dose of treatment (up to Week 52/Withdrawal [WD])","effectByArm":[{"arm":"FF/VI 100/25 µg","deltaMin":36,"sd":null},{"arm":"FF/VI 200/25 µg","deltaMin":93,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":35,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":60},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Back pain","Dysphonia","Bronchitis"]}}